Clinical trials
Phase 2 Cholangiocarcinoma trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Recruiting | 3 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 7 |
| AIO-Studien-gGmbH | 3 |
| Basilea Pharmaceutica | 1 |
| Delcath Systems Inc. | 1 |
| Fore Biotherapeutics | 1 |
| Hannover Medical School | 1 |
| Heinrich-Heine University, Duesseldorf | 1 |
| Hoffmann-La Roche | 1 |
| Incyte Corporation | 1 |
| Johannes Gutenberg University Mainz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 23 |
| Biliary Tract Neoplasms | 6 |
| Bile Duct Neoplasms | 4 |
| Gallbladder Neoplasms | 4 |
| Carcinoma, Hepatocellular | 3 |
| Ovarian Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Urinary Bladder Neoplasms | 2 |
| Acrocephalosyndactylia | 1 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.